Scientists from Sechenov University, conjointly with their fellow Chinese and American researchers, have examined the latest advances in the use of skeletal muscle progenitor cells, specifying the core challenges inherent to the applicability of MPCs in cell therapy, and outlining the most promising breakthrough technologies. The outcomes of this research were reported in Applied Physics Reviews, the article having been roundly praised by the editorial board.
* This article was originally published here
